119 related articles for article (PubMed ID: 32169399)
1. Trimethyl chitosan-hyaluronic acid nano-polyplexes for intravitreal VEGFR-2 siRNA delivery: Formulation and in vivo efficacy evaluation.
Chaharband F; Daftarian N; Kanavi MR; Varshochian R; Hajiramezanali M; Norouzi P; Arefian E; Atyabi F; Dinarvand R
Nanomedicine; 2020 Jun; 26():102181. PubMed ID: 32169399
[TBL] [Abstract][Full Text] [Related]
2. Anti-VEGF PolysiRNA Polyplex for the Treatment of Choroidal Neovascularization.
Lee J; Ryoo NK; Han H; Hong HK; Park JY; Park SJ; Kim YK; Sim C; Kim K; Woo SJ; Park KH; Kim H
Mol Pharm; 2016 Jun; 13(6):1988-95. PubMed ID: 27173745
[TBL] [Abstract][Full Text] [Related]
3. Lyophilisation and concentration of chitosan/siRNA polyplexes: Influence of buffer composition, oligonucleotide sequence, and hyaluronic acid coating.
Veilleux D; Gopalakrishna Panicker RK; Chevrier A; Biniecki K; Lavertu M; Buschmann MD
J Colloid Interface Sci; 2018 Feb; 512():335-345. PubMed ID: 29080529
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
5. Ocular implant containing bevacizumab-loaded chitosan nanoparticles intended for choroidal neovascularization treatment.
Badiee P; Varshochian R; Rafiee-Tehrani M; Abedin Dorkoosh F; Khoshayand MR; Dinarvand R
J Biomed Mater Res A; 2018 Aug; 106(8):2261-2271. PubMed ID: 29637733
[TBL] [Abstract][Full Text] [Related]
6. A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model.
Liu HA; Liu YL; Ma ZZ; Wang JC; Zhang Q
Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4789-94. PubMed ID: 21519028
[TBL] [Abstract][Full Text] [Related]
7. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
8. Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
Varkouhi AK; Verheul RJ; Schiffelers RM; Lammers T; Storm G; Hennink WE
Bioconjug Chem; 2010 Dec; 21(12):2339-46. PubMed ID: 21049986
[TBL] [Abstract][Full Text] [Related]
9. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-Polycaprolactone Core-Shell Microparticles for Sustained Delivery of Bevacizumab.
Jiang P; Jacobs KM; Ohr MP; Swindle-Reilly KE
Mol Pharm; 2020 Jul; 17(7):2570-2584. PubMed ID: 32484677
[TBL] [Abstract][Full Text] [Related]
11. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K
J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806
[TBL] [Abstract][Full Text] [Related]
12. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization.
Ryoo NK; Lee J; Lee H; Hong HK; Kim H; Lee JB; Woo SJ; Park KH; Kim H
Nanoscale; 2017 Oct; 9(40):15461-15469. PubMed ID: 28976519
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
15. Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives.
Serrano-Sevilla I; Artiga Á; Mitchell SG; De Matteis L; de la Fuente JM
Molecules; 2019 Jul; 24(14):. PubMed ID: 31311176
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.
Tolentino MJ; Brucker AJ; Fosnot J; Ying GS; Wu IH; Malik G; Wan S; Reich SJ
Retina; 2004 Feb; 24(1):132-8. PubMed ID: 15076954
[TBL] [Abstract][Full Text] [Related]
17. Anti-VEGFR2 Antibody-modified Micelle for Triggered Drug Delivery and Effective Therapy of Choroidal Neovascularization.
Takahashi K; Masuda T; Harada M; Inoue T; Nakamura S; Naito K; Hara H; Shimazawa M
Curr Neurovasc Res; 2019; 16(3):258-265. PubMed ID: 31258081
[TBL] [Abstract][Full Text] [Related]
18. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
[TBL] [Abstract][Full Text] [Related]
19. Efficient delivery of siRNA by atelocollagen in a murine laser-induced choroidal neovascularization model.
Ito Y; Nozaki M; Sugitani K; Ashikari M; Hirano Y; Ogura Y
Ophthalmologica; 2013; 230(4):215-21. PubMed ID: 24080835
[TBL] [Abstract][Full Text] [Related]
20. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells.
Parmar MB; K C RB; Löbenberg R; Uludağ H
Biomacromolecules; 2018 Nov; 19(11):4193-4206. PubMed ID: 30222931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
